Girisa Sosmitha, Parama Dey, Harsha Choudhary, Banik Kishore, Kunnumakkara Ajaikumar B
Cancer Biology Laboratory and DBT-AIST International Center for Translational and Environmental Research (DAICENTER), Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati, Assam 781039, India.
Explor Target Antitumor Ther. 2020;1(5):313-342. doi: 10.37349/etat.2020.00019. Epub 2020 Oct 30.
Cancer is one of the most dreadful diseases in the world with a mortality of 9.6 million annually. Despite the advances in diagnosis and treatment during the last couple of decades, it still remains a serious concern due to the limitations associated with currently available cancer management strategies. Therefore, alternative strategies are highly required to overcome these glitches. The importance of medicinal plants as primary healthcare has been well-known from time immemorial against various human diseases, including cancer. that belongs to Burseraceae family is one such plant which has been used to cure various ailments in traditional systems of medicine. This plant has diverse pharmacological properties such as antioxidant, antibacterial, antimutagenic, and antitumor which mostly owes to the presence of its active compound guggulsterone (GS) that exists in the form of Z- and E-isomers. Mounting evidence suggests that this compound has promising anticancer activities and was shown to suppress several cancer signaling pathways such as NF-κB/ERK/MAPK/AKT/STAT and modulate the expression of numerous signaling molecules such as the farnesoid X receptor, cyclin D1, survivin, caspases, HIF-1α, MMP-9, EMT proteins, tumor suppressor proteins, angiogenic proteins, and apoptotic proteins. The current review is an attempt to summarize the biological activities and diverse anticancer activities (both and ) of the compound GS and its derivatives, along with its associated mechanism against various cancers.
Explor Target Antitumor Ther. 2020
Curr Pharm Des. 2016
Anticancer Res. 2008
Adv Exp Med Biol. 2016
NeuroSci. 2025-6-5
Discov Oncol. 2024-2-19
Cell Mol Life Sci. 2024-2-9
Pharmaceuticals (Basel). 2023-5-17
ACS Pharmacol Transl Sci. 2023-3-6
Semin Cancer Biol. 2022-5
Crit Rev Immunol. 2020
Semin Cancer Biol. 2021-1